Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Holman

Showing results (451-460 of 716) with videos related to

Pageof 72
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 17, 2012
Following experimental stroke, the recovering brain is vulnerable to lipoxygenase-dependent semaphorin signalingAnton Pekcec, Kazim Yigitkanli, Joo Eun Jung, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 2, 2011
Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapyJohn M Lachin, Giancarlo Viberti, Bernard Zinman, et al.
Diabetologia|February 25, 2005
Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70)T M E Davis, A D Wright, Z M Mehta, et al.
Diabetes Care|August 28, 2025
International Variation in Case Fatality After Major Coronary or Cerebrovascular Events in Individuals With Type 2 Diabetes: Evidence From ADVANCE, TECOS, and EXSCELPhilip M Clarke, Xinyang Hua, Ruth L Coleman, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|July 19, 2008
Safety of contrast-enhanced echocardiography within 24 h after acute myocardial infarctionGaetano Nucifora, Nina Ajmone Marsan, Hans-Marc J Siebelink, et al.
Diabetes Care|November 20, 2025
The Role of Adaptive and Innovative Trial Designs in Diabetes Research: A Scoping ReviewAshni Goshrani, Rose Lin, Leonid Churilov, et al.
Diabetes, Obesity & Metabolism|August 1, 2024
Estimated glomerular filtration rate slope and risk of primary and secondary major adverse cardiovascular events and heart failure hospitalization in people with type 2 diabetes: An analysis of the EXSCEL trialAbderrahim Oulhaj, Faisal Aziz, Abubaker Suliman, et al.
Lancet (London, England)|April 2, 2010
Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysisRichard Kahn, Peter Alperin, David Eddy, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 20, 2012
Right ventricular longitudinal peak systolic strain measurements from the subcostal view in patients with suspected pulmonary hypertension: a feasibility studyMarlieke L A Haeck, Roderick W C Scherptong, M Louisa Antoni, et al.
Thrombosis and Haemostasis|June 21, 2013
12-lipoxygenase activity plays an important role in PAR4 and GPVI-mediated platelet reactivityJ Yeung, P L Apopa, J Vesci, et al.
Pageof 72

Showing results (451-460 of 716) with videos related to

Sort By:
Pageof 72
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 17, 2012
Following experimental stroke, the recovering brain is vulnerable to lipoxygenase-dependent semaphorin signalingAnton Pekcec, Kazim Yigitkanli, Joo Eun Jung, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 2, 2011
Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapyJohn M Lachin, Giancarlo Viberti, Bernard Zinman, et al.
Diabetologia|February 25, 2005
Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70)T M E Davis, A D Wright, Z M Mehta, et al.
Diabetes Care|August 28, 2025
International Variation in Case Fatality After Major Coronary or Cerebrovascular Events in Individuals With Type 2 Diabetes: Evidence From ADVANCE, TECOS, and EXSCELPhilip M Clarke, Xinyang Hua, Ruth L Coleman, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|July 19, 2008
Safety of contrast-enhanced echocardiography within 24 h after acute myocardial infarctionGaetano Nucifora, Nina Ajmone Marsan, Hans-Marc J Siebelink, et al.
Diabetes Care|November 20, 2025
The Role of Adaptive and Innovative Trial Designs in Diabetes Research: A Scoping ReviewAshni Goshrani, Rose Lin, Leonid Churilov, et al.
Diabetes, Obesity & Metabolism|August 1, 2024
Estimated glomerular filtration rate slope and risk of primary and secondary major adverse cardiovascular events and heart failure hospitalization in people with type 2 diabetes: An analysis of the EXSCEL trialAbderrahim Oulhaj, Faisal Aziz, Abubaker Suliman, et al.
Lancet (London, England)|April 2, 2010
Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysisRichard Kahn, Peter Alperin, David Eddy, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 20, 2012
Right ventricular longitudinal peak systolic strain measurements from the subcostal view in patients with suspected pulmonary hypertension: a feasibility studyMarlieke L A Haeck, Roderick W C Scherptong, M Louisa Antoni, et al.
Thrombosis and Haemostasis|June 21, 2013
12-lipoxygenase activity plays an important role in PAR4 and GPVI-mediated platelet reactivityJ Yeung, P L Apopa, J Vesci, et al.
Pageof 72